Published in J Clin Oncol on October 22, 2012
Considerations for observational research using large data sets in radiation oncology. Int J Radiat Oncol Biol Phys (2014) 2.06
When retrospective comparative effectiveness research hinders science and patient-centered care. J Clin Oncol (2013) 1.08
Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer. Breast Cancer Res Treat (2013) 0.87
Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer. J Natl Cancer Inst (2014) 0.84
For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery. Surgery (2013) 0.82
Utilization and Outcomes of Breast Brachytherapy in Younger Women. Int J Radiat Oncol Biol Phys (2015) 0.82
Physician's peer exposure and the adoption of a new cancer treatment modality. Cancer (2015) 0.80
When hope hinders science and patient-centered care. J Clin Oncol (2012) 0.79
The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer. Health Serv Res (2015) 0.78
The incidence of fat necrosis in balloon-based breast brachytherapy. J Contemp Brachytherapy (2015) 0.78
[Evaluation of (balloon) brachytherapy for partial breast irradiation in breast cancer based on current meta-analyses]. Strahlenther Onkol (2013) 0.77
Reply to L.W. Cuttino et al. J Clin Oncol (2013) 0.77
Survival after partial breast brachytherapy in elderly patients with nonmetastatic breast cancer. Brachytherapy (2013) 0.76
Response. J Natl Cancer Inst (2014) 0.75
How can we best respect patient autonomy in breast cancer treatment decisions? Breast Cancer Manag (2015) 0.75
Balloon brachytherapy for breast cancer prove that it works? Or, prove that it doesn't? J Cancer Res Clin Oncol (2014) 0.75
Comorbidity measures for use with administrative data. Med Care (1998) 46.67
Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA (1994) 11.32
Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA (2008) 5.66
Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health (1998) 5.55
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med (2001) 4.72
NIH consensus conference. Treatment of early-stage breast cancer. JAMA (1991) 4.35
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys (2009) 3.91
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Serv Res (2004) 2.75
Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys (2003) 2.56
Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol (2001) 2.37
Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial. Int J Radiat Oncol Biol Phys (2007) 2.03
Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance. J Natl Cancer Inst (2011) 1.92
Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med (2009) 1.68
The relationship between hospital volume and mortality in mechanical ventilation: an instrumental variable analysis. Health Serv Res (2009) 1.63
Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg (2007) 1.61
Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. Int J Radiat Oncol Biol Phys (2007) 1.60
Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol (2004) 1.56
Mortality benefit of transfer to level I versus level II trauma centers for head-injured patients. Health Serv Res (2005) 1.51
Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator. Breast J (2005) 1.48
Invasive breast cancer. J Natl Compr Canc Netw (2011) 1.43
Accelerated Partial Breast Irradiation (APBI): A review of available techniques. Radiat Oncol (2010) 1.37
Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2010) 1.34
Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol (2010) 1.33
Does aggressive care following acute myocardial infarction reduce mortality? Analysis with instrumental variables to compare effectiveness in Canadian and United States patient populations. Health Serv Res (2003) 1.23
Survival advantage associated with treatment of injury at designated trauma centers: a bivariate probit model with instrumental variables. Med Care Res Rev (2007) 1.16
Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer (2011) 1.13
Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys (2007) 0.98
Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation. Cancer (2012) 0.94
Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys (2005) 0.93
Partial breast irradiation with interstitial high-dose-rate brachytherapy in early breast cancer: results of a phase II prospective study. Eur J Surg Oncol (2008) 0.92
Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Int J Radiat Oncol Biol Phys (2012) 0.86
Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity. Brachytherapy (2009) 0.82
Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88
Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics (2011) 7.15
Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity. J Clin Oncol (2014) 6.62
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol (2011) 4.07
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation (2005) 3.78
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst (2012) 3.72
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J (2003) 3.11
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res (2007) 3.08
Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol (2012) 3.07
Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. JAMA (2007) 3.03
Recruiting vulnerable populations into research: a systematic review of recruitment interventions. J Gen Intern Med (2007) 3.02
Health and social services expenditures: associations with health outcomes. BMJ Qual Saf (2011) 2.98
Evaluating obstetrical residency programs using patient outcomes. JAMA (2009) 2.93
Effectiveness and cost of a transitional care program for heart failure: a prospective study with concurrent controls. Arch Intern Med (2011) 2.88
Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann Intern Med (2012) 2.86
Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA (2003) 2.77
Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst (2006) 2.69
Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys (2010) 2.66
Cluster randomised controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat. BMJ (2002) 2.58
The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med (2012) 2.48
Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol (2007) 2.46
Effect of blinded peer review on abstract acceptance. JAMA (2006) 2.38
The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care (2011) 2.38
Sharing of clinical trial data among trialists: a cross sectional survey. BMJ (2012) 2.31
Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system. Oncology (Williston Park) (2012) 2.29
Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg (2012) 2.28
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol (2012) 2.18
The importance of clinical trial data sharing: toward more open science. Circ Cardiovasc Qual Outcomes (2012) 2.16
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology (2013) 2.16
Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care (2014) 2.14
Improvements in door-to-balloon time in the United States, 2005 to 2010. Circulation (2011) 2.13
NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01
Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park) (2010) 2.01
Anesthesiologist involvement in screening colonoscopy: temporal trends and cost implications in the medicare population. Clin Gastroenterol Hepatol (2011) 1.97
Use of hospital-based acute care among patients recently discharged from the hospital. JAMA (2013) 1.88
Hospice characteristics and the disenrollment of patients with cancer. Health Serv Res (2009) 1.86
Medical messages in the media--barriers and solutions to improving medical journalism. Health Expect (2003) 1.84
Interdisciplinary staffing patterns: do for-profit and nonprofit hospices differ? J Palliat Med (2010) 1.84
Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database Syst Rev (2011) 1.81
Physician violations of online professionalism and disciplinary actions: a national survey of state medical boards. JAMA (2012) 1.81
Impact of hospice disenrollment on health care use and medicare expenditures for patients with cancer. J Clin Oncol (2010) 1.81
Assessing the impact of screening colonoscopy on mortality in the medicare population. J Gen Intern Med (2011) 1.73
Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction. Med Care (2005) 1.73
Population based cancer registry analysis of primary tracheal carcinoma. Am J Clin Oncol (2011) 1.71
A retrospective review of 1349 cases of sebaceous carcinoma. Cancer (2009) 1.70
Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol (2005) 1.69
Comparison of directed and self-directed learning in evidence-based medicine: a randomised controlled trial. Med Educ (2005) 1.64
Validation of the partin nomogram for prostate cancer in a national sample. J Urol (2010) 1.64
Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database. J Urol (2010) 1.64
Laparoscopic colectomy for the treatment of cancer has been widely adopted in the United States. Dis Colon Rectum (2012) 1.62
Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population. Arch Dermatol (2012) 1.60
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.59
National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. J Am Coll Cardiol (2009) 1.57
Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes. Leuk Res (2009) 1.57
Blind faith? The effects of promoting active sick leave for back pain patients: a cluster-randomized controlled trial. Spine (Phila Pa 1976) (2002) 1.55
The cost of breast cancer screening in the Medicare population. JAMA Intern Med (2013) 1.53
Geographical information systems: applications and limitations in oncology research. Oncology (Williston Park) (2011) 1.52
Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients? Circulation (2003) 1.50
Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care. Med Care (2014) 1.50
Quality of care in the US territories. Arch Intern Med (2011) 1.49
A randomized outpatient trial of a decision-support information technology tool. Arch Intern Med (2005) 1.49
Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health (2011) 1.46
A historic moment for open science: the Yale University Open Data Access project and medtronic. Ann Intern Med (2013) 1.45
Physician specialty and mortality among elderly patients hospitalized with heart failure. Am J Med (2005) 1.45
Primary care, generalism, public good: déjà vu? Again! Ann Intern Med (2005) 1.45